The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis.
CXCL9
Cytokine
Macrophage activation syndrome
Platelet
Systemic juvenile idiopathic arthritis
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
20
11
2022
revised:
25
01
2023
accepted:
15
02
2023
pubmed:
23
2
2023
medline:
15
3
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
To validate the correlation between laboratory markers reflecting disease activity of macrophage activation syndrome (MAS) and serum cytokine levels and identify the valuable laboratory markers that change over time for a prompt MAS diagnosis. Serum cytokine levels were determined by enzyme-linked immunosorbent assay and compared with laboratory markers reflecting MAS disease activity.The changes in values were evaluated from the acute phase of systemic juvenile idiopathic arthritis (s-JIA) to MAS diagnosis. CXCL9 was significantly correlated with aspartate aminotransferase (AST), lactate dehydrogenase (LDH), D dimer, and urine β2 microglobulin levels. sTNF-RII was significantly correlated with platelet counts, AST, LDH, D dimer, and ferritin levels. Significant changes in platelet count, LDH, and D dimer levels were observed. Decreased platelet counts were the most valuable indicator for MAS diagnosis. Monitoring the laboratory markers that change over time, particularly decreased platelet counts, was valuable for the prompt MAS diagnosis in s-JIA.
Identifiants
pubmed: 36806704
pii: S1521-6616(23)00049-9
doi: 10.1016/j.clim.2023.109270
pii:
doi:
Substances chimiques
Cytokines
0
Biomarkers
0
Fibrin Fibrinogen Degradation Products
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109270Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest This research was supported by grants from Medical and Biological Laboratories Co., Ltd., Japan. Tokyo Medical and Dental University received unrestricted research grants for the salary of Prof. Masaaki Mori from Abbvie Japan, Asahi-Kasei, Ayumi Pharmaceutical Corporation, Chugai Pharmaceutical Co., Ltd., CSL Behring K.K., Japan Blood Products Organization, Nippon Kayaku and UCB Japan Co. Ltd., while TMDU paid the salary of MM. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.